IHC staining of the CYGB-expressing tumors showed lower GLUT1 and HXK2 and higher TIGAR expression (Fig. 8d), substantiating that CYGB suppresses breast cancer through the regulation of these key glucose metabolism factors. This evidence concerns the gene HK2 and breast cancer.